Development of lipid-shell and polymer core nanoparticles with water-soluble salidroside for anti-cancer therapy

International Journal of Molecular Sciences

Volumn 15, Issue 3, 2014, Pages 3373-3388

  Fang, Dai Long ^a   Chen, Yan ^a   Xu, Bei ^a   Ren, Ke ^b   He, Zhi Yao ^a   He, Li Li ^c   Lei, Yi ^a   Fan, Chun Mei ^a   Song, Xiang Rong ^a  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c SOUTHWEST UNIVERSITY FOR NATIONALITIES   (China)

Author keywords

Antitumor; Lipid shell and polymer core nanoparticles (LPNPs); PLGA; Salidroside

Indexed keywords

SALIDROSIDE; SOLID LIPID NANOPARTICLE; ANTINEOPLASTIC AGENT; GLUCOSIDE; LIPID; MACROGOL DERIVATIVE; NANOPARTICLE; PHENOL DERIVATIVE; POLY(LACTIC-CO-GLYCOLIC ACID)-POLYETHYLENE GLYCOL-POLY(LACTIC-CO-GLYCOLIC ACID); POLYGLACTIN; POLYMER; SOLVENT; WATER;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CANCER THERAPY; CELL VIABILITY; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIPOPHILICITY; MOUSE; MTT ASSAY; NANOENCAPSULATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG FORMULATION; SOLUBILITY; TOXICITY; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG COMPOUNDING; GLUCOSIDES; HUMANS; LIPIDS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PHENOLS; POLYETHYLENE GLYCOLS; POLYGLACTIN 910; POLYMERS; SOLUBILITY; SOLVENTS; WATER;

EID: 84895435193     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15033373     Document Type: Article

References (46)

1. Hu, X.; Lin, S.; Yu, D.; Qiu, S.; Zhang, X.; Mei, R. A preliminary study: The anti-proliferation effect of salidroside on different human cancer cell lines. Cell Biol. Toxicol. 2010, 26, 499-507.
2. Chen, S.F.; Tsai, H.J.; Hung, T.H.; Chen, C.C.; Lee, C.Y.; Wu, C.H.; Wang, P.Y.; Liao, N.C. Salidroside improves behavioral and histological outcomes and reduces apoptosis via PI3K/Akt signaling after experimental traumatic brain injury. PLoS One 2012, 7, e45763.
3. Zhang, S.; Chen, X.; Yang, Y.; Zhou, X.; Liu, J.; Ding, F. Neuroprotection against cobalt chloride-induced cell apoptosis of primary cultured cortical neurons by salidroside. Mol. Cell Biochem. 2011, 354, 161-170.
4. Sun, L.; Isaak, C.K.; Zhou, Y.; Petkau, J.C.; Karmin, O.; Liu, Y.; Siow, Y.L. Salidroside and tyrosol from Rhodiola protect H9c2 cells from ischemia/reperfusion-induced apoptosis. Life Sci. 2012, 91, 151-158.
5. Zhu, Y.; Shi, Y.P.; Wu, D.; Ji, Y.J.; Wang, X.; Chen, H.L.; Wu, S.S.; Huang, D.J.; Jiang, W. Salidroside protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via PI3K-Akt dependent pathway. DNA Cell Biol. 2011, 30, 809-819.
6. Yu, P.; Hu, C.; Meehan, E.J.; Chen, L. X-ray crystal structure and antioxidant activity of salidroside, a phenylethanoid glycoside. Chem. Biodivers. 2007, 4, 508-513.
7. Qian, E.W.; Ge, D.T.; Kong, S.K. Salidroside protects human erythrocytes against hydrogen peroxide-induced apoptosis. J. Nat. Prod. 2012, 75, 531-537.
8. Zhang, L.; Yu, H.; Sun, Y.; Lin, X.; Chen, B.; Tan, C.; Cao, G.; Wang, Z. Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. Eur. J. Pharmacol. 2007, 564, 18-25.
9. Liu, Z.; Li, X.; Simoneau, A.R.; Jafari, M.; Zi, X. Rhodiola rosea extracts and salidroside decrease the growth of bladder cancer cell lines via inhibition of the mTOR pathway and induction of autophagy. Mol. Carcinog. 2012, 51, 257-267.
10. Hu, X.; Zhang, X.; Qiu, S.; Yu, D.; Lin, S. Salidroside induces cell-cycle arrest and apoptosis in human breast cancer cells. Biochem. Biophys. Res. Commun. 2010, 398, 62-67.
11. Jia, W.; Wang, M.-L.; Yang, C.-Q. Pharmacokinetics of salidroside in rats. J. Shenyang Pharm. Univ. 2010, 27, 65-68.
12. Mao, Y.; Zhang, X.; Lu, G. Development of an HPLC method for the determination of salidroside in beagle dog plasma after administration of salidroside injection: Application to a pharmacokinetics study. J. Sep. Sci. 2007, 30, 3218-3222.
13. Andreeva, L.I.; Boikova, A.A.; Nikiforova, D.V. Evaluating adaptogenic properties of Rhodiola rosea extract in human mononuclear cell culture and rat tissues. Eksp. Klin. Farmakol. 2013, 76, 23-27.
14. Zhang, J.; Song, L.; Kong, W.; Shao, T.; Wen, X.; Liu, P.; Chai, X. Study on effect and mechanism of salidroside on cognitive ability of Abeta1-40-induced Alzheimer's disease model rats. Chin. J. Chin. Mater. Med. 2012, 37, 2122-2126.
15. Peng, H.; Dong, R.; Wang, S.; Zhang, Z.; Luo, M.; Bai, C.; Zhao, Q.; Li, J.; Chen, L.; Xiong, H. A pH-responsive nano-carrier with mesoporous silica nanoparticles cores and poly(acrylic acid) shell-layers: Fabrication, characterization and properties for controlled release of salidroside. Int. J. Pharm. 2013, 446, 153-159.
16. Fan, M.; Xu, S.; Xia, S.; Zhang, X. Preparation of salidroside nano-liposomes by ethanol injection method and in vitro release study. Eur. Food Res. Technol. 2007, 227, 167-174.
17. He, L.-L.; Deng, L.; Lin, Y.-Z. Preparation and in vitro drug release properties of salidroside-chitosan nanoparticles. Chin. Tradit. Herb. Drugs 2013, 44, 552-556.
18. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J. Control. Release 2000, 65, 271-284.
19. Hadinoto, K.; Sundaresan, A.; Cheow, W.S. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review. Eur. J. Pharm. Biopharm. 2013, doi:10.1016/j.ejpb. 2013.07.002.
20. Zhao, P.; Wang, H.; Yu, M.; Liao, Z.; Wang, X.; Zhang, F.; Ji, W.; Wu, B.; Han, J.; Zhang, H.; et al. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: In vitro and in vivo evaluation. Eur. J. Pharm. Biopharm. 2012, 81, 248-256.
21. Chitkara, D.; Kumar, N. BSA-PLGA-Based core-shell nanoparticles as carrier system for water-soluble drugs. Pharm. Res. 2013, 30, 2396-2409.
22. Chang, G.; Ci, T.; Yu, L.; Ding, J. Enhancement of the fraction of the active form of an antitumor drug topotecan via an injectable hydrogel. J. Control. Release 2011, 156, 21-27.
23. Yu, L.; Zhang, Z.; Ding, J. Influence of LA and GA sequence in the PLGA block on the properties of thermogelling PLGA-PEG-PLGA block copolymers. Biomacromolecules 2011, 12, 1290-1297.
24. Fan, M.; Xu, S.; Xia, S.; Zhang, X. Effect of different preparation methods on physicochemical properties of salidroside liposomes. J. Agric. Food Chem. 2007, 55, 3089-3095.
25. Song, X.; Zhao, Y.; Hou, S.; Xu, F.; Zhao, R.; He, J.; Cai, Z.; Li, Y.; Chen, Q. Dual agents loaded PLGA nanoparticles: Systematic study of particle size and drug entrapment efficiency. Eur. J. Pharm. Biopharm. 2008, 69, 445-453.
26. Khalil, N.M. Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats. Colloids Surf. B 2013, 101, 353-360.
27. Buske, J.; Konig, C.; Bassarab, S.; Lamprecht, A.; Muhlau, S.; Wagner, K.G. Influence of PEG in PEG-PLGA microspheres on particle properties and protein release. Eur. J. Pharm. Biopharm. 2012, 81, 57-63.
28. Liu, Y.; Pan, J.; Feng, S.S. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: Effects of surfactants on particles size, characteristics and in vitro performance. Int. J. Pharm. 2010, 395, 243-250.
29. Yu, Y.; He, Y.; Xu, B.; He, Z.; Zhang, Y.; Chen, Y. Self-assembled methoxy poly(ethylene glycol)-cholesterol micelles for hydrophobic drug delivery. J. Pharm. Sci. 2013, 102, 1054-1062.
30. Ravi Kumar, M.N.; Bakowskym, U.; Lehr, C.M. Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials 2004, 25, 1771-1777.
31. Ozturk, K.; Caban, S.; Kozlu, S.; Kadayifci, E.; Yerlikaya, F.; Capan, Y. The influence of technological parameters on the physicochemical properties of blank PLGA nanoparticles. Pharmazie 2010, 65, 665-669.
32. Li, H.; Shi, Q.W.; Chang, L.Q.; Jin, S.Y. Disscussion on the position of shear plane. J. Colloid Int. Sci. 2003, 285, 40-44.
33. He, Z.Y.; Zheng, X.; Wu, X.H.; Song, X.R.; He, G.; Wu, W.F. Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery. Int. J. Pharm. 2010, 397, 147-154.
34. Cui, F.Y.; Song, X.R.; Li, Z.Y.; Li, S.Z.; Mu, B.; Mao, Y.Q.; Wei, Y.Q.; Yang, L. The pigment epithelial-derived factor gene loaded in PLGA nanoparticles for therapy of colon carcinoma. Oncol. Rep. 2010, 24, 661-668.
35. Wang, H.; Zhao, P.; Su, W.; Wang, S.; Liao, Z.; Niu, R.; Chang, J. PLGA/polymeric liposome for targeted drug and gene co-delivery. Biomaterials 2010, 31, 8741-8748.
36. Mussi, S.V.; Silva, R.C.; Oliveira, M.C.; Lucci, C.M.; Azevedo, R.B.; Ferreira, L.A. New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles. Eur. J. Pharm. Sci. 2013, 48, 282-290.
37. Werner, M.E.; Karve, S.; Sukumar, R.; Cummings, N.D.; Copp, J.A.; Chen, R.C.; Zhang, T.; Wang, A.Z. Folate-targeted nanoparticle delivery of chemo-and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis. Biomaterials 2011, 32, 8548-8554.
38. Anderson, T.H. Formation of supported bilayers on silica substrates. Langmuir 2009, 25, 6997-7005.
39. Michel, R.; Gradzielski, M. Experimental aspects of colloidal interactions in mixed systems of liposome and inorganic nanoparticle and their applications. Int. J. Mol. Sci. 2012, 13, 11610-11642.
40. Li, J.; He, Z.; Yu, S.; Li, S.; Ma, Q.; Yu, Y.; Zhang, J.; Li, R.; Zheng, Y.; He, G.; et al. Micelles based on methoxy poly(ethylene glycol)-cholesterol conjugate for controlled and targeted drug delivery of a poorly water soluble drug. J. Biomed. Nanotechnol. 2012, 8, 809-817.
41. Pan, H.J.; Nie, X.Q.; Liu, D.; Bian, K. Effects of four kinds of Chinese medicine monomer on growth of PANC-1 xenograft tumor and studying of molecular mechanism. China J. Chin. Mater. Med. 2013, 38, 245-248.
42. Xie, M.; Zhang, H.; Xu, Y.; Liu, T.; Chen, S.; Wang, J.; Zhang, T. Expression of folate receptors in nasopharyngeal and laryngeal carcinoma and folate receptor-mediated endocytosis by molecular targeted nanomedicine. Int. J. Nanomed. 2013, 8, 2443-2451.
43. Yu, L.; Chang, G.T.; Zhang, H.; Ding, J.D. Injectable block copolymer hydrogels for sustained release of a PEGylated drug. Int. J. Pharm. 2008, 348, 95-106.
44. Yu, L.; Zhang, Z.; Zhang, H.; Ding, J. Mixing a sol and a precipitate of block copolymers with different block ratios leads to an injectable hydrogel. Biomacromolecules 2009, 10, 1547-1553.
45. Peng, Y.; Luo, J.; Lu, Q.; Chen, X.; Xie, Y.; Chen, L.; Yang, W.; Du, S. HPLC analysis, semi-preparative HPLC preparation and identification of three impurities in salidroside bulk drug. J. Pharm. Biomed. Anal. 2009, 49, 828-832.
46. Song, X.R.; Zheng, Y.; He, G.; Yang, L.; Luo, Y.F.; He, Z.Y.; Li, S.Z.; Li, J.M.; Yu, S.; Luo, X.; et al. Development of PLGA nanoparticles simultaneously loaded with vincristine and verapamil for treatment of hepatocellular carcinoma. J. Pharm. Sci. 2010, 99, 4874-4879.